Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MedTech Europe Urges EU To Support European Health Data Space Proposal

Executive Summary

The European Commission’s proposed Regulation on the European Health Data Space has been broadly met with optimism by MedTech Europe. While some fine-tuning is needed, the trade body believes the initiative will help align health data across the EU.

You may also be interested in...

EHDS Data Sharing Rules Are Good News For Medtech, But Is The Public On Board?

The medtech industry is set to benefit from access to large amounts of patient health data  under the proposed European Health Data Space, but a new report reveals that EU citizens would like more control in how their data are used.

Genomics England Taps Medical Imaging Firm Sectra To Bolster Cancer Research

Genomics England, a UK government-owned genomic sequencing company, has joined forces with Swedish medical imaging and cybersecurity firm Sectra to “push the boundaries” of cancer research by linking up cancer images from NHS trusts data with genomics data and AI.

EU Digital Tech Trade Body Weighs In On Medical Device ‘Over-Regulation’ Risk

While the European Health Data Space and its objectives should be a positive regulatory development for the EU health sector, DIGITALEUROPE stresses that the risk of counterproductive conflicts with other proposed laws around AI and data must be addressed.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts